Jane Street Group LLC Buys 42,976 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Jane Street Group LLC grew its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 190.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 65,500 shares of the company’s stock after purchasing an additional 42,976 shares during the period. Jane Street Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $943,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Estabrook Capital Management acquired a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $35,000. Blue Bell Private Wealth Management LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 1.8% in the 4th quarter. Blue Bell Private Wealth Management LLC now owns 186,084 shares of the company’s stock worth $2,680,000 after acquiring an additional 3,352 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 3.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 102,437 shares of the company’s stock worth $1,475,000 after acquiring an additional 3,635 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 24.9% in the 4th quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock worth $378,000 after acquiring an additional 5,224 shares in the last quarter. Finally, Brown Lisle Cummings Inc. boosted its holdings in shares of BlackRock Health Sciences Term Trust by 17.0% in the 4th quarter. Brown Lisle Cummings Inc. now owns 42,711 shares of the company’s stock worth $615,000 after acquiring an additional 6,198 shares in the last quarter.

BlackRock Health Sciences Term Trust Price Performance

Shares of BMEZ opened at $14.24 on Friday. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $16.75. The business’s 50 day simple moving average is $14.31 and its 200-day simple moving average is $15.13.

BlackRock Health Sciences Term Trust Cuts Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, May 30th. Stockholders of record on Thursday, May 15th will be issued a $0.1712 dividend. This represents a $2.05 annualized dividend and a dividend yield of 14.43%. The ex-dividend date is Thursday, May 15th.

BlackRock Health Sciences Term Trust Company Profile

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Read More

Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.